Early Manifest Glaucoma Trial: Design and baseline data

Ophthalmology

Volumn 106, Issue 11, 1999, Pages 2144-2153

  Leske, M Cristina ^a   Heijl, Anders ^b   Hyman, Leslie ^a   Bengtsson, Bo ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SWEDEN; TRABECULOPLASTY; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

EID: 0033498278     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90497-9     Document Type: Article

References (38)

1. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983;118:166-91.
2. Lundberg L, Wettrell K, Linnér E. Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol (Copenh) 1987;65:705-8.
3. Anderson DR. Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol 1989;108:485-95.
4. American Academy of Ophthalmology. Primary open-angle glaucoma. Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthalmology, 1992.
5. Rossetti L, Marchetti I, Orzalesi N, et al. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol 1993;111:96-103.
6. Schulzer M, Drance SM, Douglas GR. A comparison of treated and untreated glaucoma suspects. Ophthalmology 1991;98:301-7.
7. Kass MA, Gordon MO, Hoff MR, et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol 1989;107:1590-8.
8. Epstein DL, Krug JH, Jr, Hertzmark E, et al. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 1989;96:1460-7.
9. Heijl A. The Malmö high risk ocular hypertension study. J Glaucoma 1993;2 (Suppl A):S5-7.
10. Holmin C, Thorburn W, Krakau CET. Treatment versus no treatment in chronic open angle glaucoma. Acta Ophthalmol (Copenh) 1988;66:170-3.
11. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126: 498-505.
12. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998; 126:487-97.
13. Leske MC, Hyman L, Hussein M, et al. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma [letter]. Am J Ophthalmol 1999;127:625.
14. Anderson DR, Drance SM, Schulzer M. Author reply [letter]. Am J Ophthalmol 1999;127:625-6. Response to: Am J Ophthalmol 1999;127:625.
15. Anderson DR, Drance SM, Schulzer M. Author reply [letter]. Am J Ophthalmol 1999;127:625-6. Response to: Am J Ophthalmol 1999;127:625.
16. Eddy DM, Sanders LE, Eddy JF. The value of screening for glaucoma with tonometry. Surv Ophthalmol 1983;28:194-205.
17. Leske MC, Rosenthal J. Epidemiologic aspects of open-angle glaucoma. Am J Epidemiol 1979;109:250-72.
18. Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. In: Greve EL, Heijl A, eds. Seventh Int'l Visual Field Symp. 1986. Dordrecht: Martinus Nijhoff/ Dr W. Junk, 1987;153-68 (Doc Ophthalmol Proc Ser; 49).
19. Heijl A, Lindgren G, Lindgren A, et al. Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: Statpac 2. In: Mills RP, Heijl A, eds. Perimetry Update 1990/91. Proceedings of the IXth International Perimetric Society Meeting. Amsterdam; New York: Kugler Publications, 1991;303-15.
20. Asman P, Heijl A. Glaucoma hemifield test. Automated visual field evaluation. Arch Ophthalmol 1992;110:812-9.
21. Asman P, Heijl A. Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 1992;110:820-6.
22. Katz J, Sommer A, Gaasterland DE, Anderson DR. Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol 1991;109:1684-9.
23. Chylack LT Jr, Leske MC, McCarthy D, et al. Lens Opacities Classification System II (LOGS II). Arch Ophthalmol 1989; 107:991-7.
24. Bengtsson B, Krakau CET. Flicker comparison of fundus photographs: a technical note. Acta Ophthalmol (Copenh) 1979;57:503-6.
25. Heijl A, Bengtsson B. Diagnosis of early glaucoma with flicker comparisons of serial disc photographs. Invest Ophthalmol Vis Sci 1989;30:2376-84.
26. Flammer J, Drance SM, Schulzer M. Covariates of the long-term fluctuation of the differential light threshold. Arch Ophthalmol 1984;102:880-2.
27. Heijl A, Lindgren A, Lindgren G. Test-retest variability in glaucomatous visual fields. Am J Ophthalmol 1989;108:130-5.
28. Heijl A, Bengtsson B. The effect of perimetric experience in patients with glaucoma. Arch Ophthalmol 1996;114:19-22.
29. Bengtsson B, Lindgren A, Heijl A, et al. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand 1997;75:184-8.
30. Bengtsson B. Glaucoma case detection. Acta Ophthalmol (Copenh) 1991;69:288-92.
31. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
32. Liang KY, Zeger SL. Longitudinal data-analysis using generalized linear-models. Biometrika 1986;73:13-22.
33. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44:1049-60.
34. Rosner B. Multivariate methods in ophthalmology with application to other paired-data situations. Biometrics 1984;40:1025-35.
35. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81: 515-26.
36. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994;15:299-325.
37. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol 1974;13:455-7.
38. Pederson JE, Gaasterland DE. Laser-induced primate glaucoma. I. Progression of cupping. Arch Ophthalmol 1984;102:1689-92.